| scholarly article | Q13442814 |
| P50 | author | Darlene Miller | Q55483430 |
| Nidhi Relhan | Q86969076 | ||
| Ajay E Kuriyan | Q86969078 | ||
| Harry W Flynn | Q89902165 | ||
| Laura Huang | Q90712769 | ||
| Ella H Leung | Q92342586 | ||
| P2860 | cites work | Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits | Q46775309 |
| Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis | Q68097709 | ||
| Intraocular distribution of intravitreally administered amphotericin B in normal and vitrectomized eyes | Q69751288 | ||
| Role of intravitreal dexamethasone in exogenous fungal endophthalmitis | Q73496560 | ||
| Clearance of intravitreal voriconazole | Q80219545 | ||
| Bleb-associated endophthalmitis: clinical characteristics and visual outcomes | Q80407452 | ||
| Risk factors for post-traumatic endophthalmitis in patients with positive intraocular cultures | Q80727611 | ||
| Endophthalmitis following open-globe injuries | Q27002960 | ||
| Antifungal drug resistance of pathogenic fungi. | Q34594076 | ||
| Reliability of vitreous histological detection of pathogenic fungi in the diagnosis of fungal endophthalmitis | Q35196834 | ||
| Glaucoma drainage devices: risk of exposure and infection | Q35977499 | ||
| Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs | Q36089061 | ||
| Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes | Q36374205 | ||
| Fungal endophthalmitis associated with compounded products | Q37513509 | ||
| Management of recurrent postoperative fungal endophthalmitis | Q37733421 | ||
| Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention | Q38181581 | ||
| Recent Clinical Manifestation and Prognosis of Fungal Endophthalmitis: A 7-Year Experience at a Tertiary Referral Center in Korea | Q38424711 | ||
| Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole | Q39803132 | ||
| Resolving the clinical acuity categories "hand motion" and "counting fingers" using the Freiburg Visual Acuity Test (FrACT). | Q40051827 | ||
| Long-Term Bleb-Related Infections After Trabeculectomy: Incidence, Risk Factors, and Influence of Bleb Revision | Q41444711 | ||
| Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010). | Q41634462 | ||
| Incidence of endophthalmitis after corneal transplant or cataract surgery in a medicare population. | Q42249205 | ||
| Incidence of bleb-associated endophthalmitis in the United States | Q43141637 | ||
| Exogenous fungal endophthalmitis: microbiology and clinical outcomes | Q46590776 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 45-50 | |
| P577 | publication date | 2016-09-16 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | Persistently Vitreous Culture-Positive Exogenous Fungal Endophthalmitis | |
| P478 | volume | 172 |
| Q64881604 | Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile. | cites work | P2860 |
Search more.